All Adam Pearson articles

  • CAR-T-cell-therapy-oncology
    News

    Astellas to advance oncology CAR-T therapy

    2023-08-07T17:43:43Z

    An investment of $50 million by Astellas Pharma in Poseida Therapeutics’ Phase I allogeneic CAR-T product candidate for solid tumour indications is set to advance the cancer immunotherapy field.

  • management big pharma
    News

    Astellas and Bayer announce management changes

    2023-02-10T12:54:05Z

    Two Big Pharma companies have announced management changes in 2023: Astellas will have a new President and CEO and Bayer AG will be led by a new CEO.